Capital International’s bluebird bio BLUE Stock Holding History

Capital International’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-81	Closed	-$48K	–	173
2020 Q1	$48K	Sell	81 -30	-27%	-$29.2K	0.01%	174
2019 Q4	$126K	Sell	111 -770	-87%	-$837K	0.01%	136
2019 Q3	$1.05M	Buy	881 +421	+92%	+$643K	0.16%	109
2019 Q2	$758K	Buy	460 +13	+3%	+$22.5K	0.18%	106
2019 Q1	$910K	Sell	447 -11	-2%	-$19.4K	0.22%	101
2018 Q4	$588K	Buy	458 +49	+12%	+$75.2K	0.16%	103
2018 Q3	$774K	Sell	409 -679	-62%	-$1.4M	0.24%	93
2018 Q2	$2.21M	Buy	1,088 +517	+91%	+$1.18M	0.39%	76
2018 Q1	$1.26M	Buy	+571	New	+$1.45M	0.23%	110

Other funds holding BLUE

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital International's BLUE Position: Q2 2020 in Review

Capital International sold out of bluebird bio (BLUE) in Q2 2020, closing a stake of 81 shares — an estimated $48K sold.

Capital International first reported a position in BLUE in Q1 2018 and held it in 9 quarters. The position peaked at $2.21M in Q2 2018. 278 funds tracked by Wall St. Rank hold BLUE as of Q2 2020.

Capital International reported no remaining bluebird bio position as of Q2 2020 after selling out during the quarter.
Capital International sold 81 bluebird bio shares in Q2 2020, an estimated $48K.
Capital International first reported a position in bluebird bio in Q1 2018 and held it in 9 quarters.
Capital International's bluebird bio position peaked at $2.21M in Q2 2018.
278 funds tracked by Wall St. Rank held bluebird bio as of Q2 2020.

Based on Capital International's 13F filing for Q2 2020, filed 14 Aug 2020.